Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

New AFib guidelines update recommendations for ablation, LAAO | Progress for total artificial heart technology

News You Need to Know Today
New AFib guidelines update recommendations for ablation, LAAO | Progress for total artificial heart technology
Monday, December 4, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

New AFib guidelines include higher recommendations for catheter ablation, LAAO

Cardiologists, electrophysiologists, surgeons and patient representatives all worked together on the updated guidelines, which were published in both the Journal of the American College of Cardiology and Circulation.

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

New AFib guidelines include higher recommendations for catheter ablation, LAAO

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Cardiologists, electrophysiologists, surgeons and patient representatives all worked together on the updated guidelines, which were published in both the Journal of the American College of Cardiology and Circulation.
READ MORE >

FDA approves early feasibility study for total artificial heart technology

The device is intended to be a bridge for heart failure patients waiting to receive a full heart transplant.

READ MORE >
BiVACOR Total Artificial Heart. BiVACOR, an international medical device company with headquarters in the United States and Australia, has received approval from the U.S. Food and Drug Administration (FDA) to kick off an early feasibility study (EFS) for its total artificial heart (TAH) technology.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves early feasibility study for total artificial heart technology

Share on Twitter Share on Facebook Share on Linkedin
BiVACOR Total Artificial Heart. BiVACOR, an international medical device company with headquarters in the United States and Australia, has received approval from the U.S. Food and Drug Administration (FDA) to kick off an early feasibility study (EFS) for its total artificial heart (TAH) technology.
The device is intended to be a bridge for heart failure patients waiting to receive a full heart transplant.
READ MORE >

Featured Articles

First US patient treated with Medtronic’s FDA-approved renal denervation system

Interventional cardiologist David Kandzari, MD, performed the procedure just days after the device received full FDA approval. 

READ MORE >
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
Share on Twitter Share on Facebook Share on Linkedin

First US patient treated with Medtronic’s FDA-approved renal denervation system

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
Interventional cardiologist David Kandzari, MD, performed the procedure just days after the device received full FDA approval. 
READ MORE >

Johnson & Johnson acquires medical device company behind new LAA technology for $400M

The deal could also include additional clinical and regulatory milestone payments in the years ahead.

READ MORE >
business news announcement
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson acquires medical device company behind new LAA technology for $400M

Share on Twitter Share on Facebook Share on Linkedin
business news announcement
The deal could also include additional clinical and regulatory milestone payments in the years ahead.
READ MORE >

‘We should halt this practice’: Common hormone treatment for donated hearts may be harmful

"This practice has been adopted by multiple organ-procurement organizations and is used on thousands of organ donors each year, without ever having been rigorously studied," one researcher said. 

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

‘We should halt this practice’: Common hormone treatment for donated hearts may be harmful

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
"This practice has been adopted by multiple organ-procurement organizations and is used on thousands of organ donors each year, without ever having been rigorously studied," one researcher said. 
READ MORE >

In Case You Missed It

Daily marijuana use increases heart failure risk by 34%

“Marijuana use isn’t without its health concerns, and our study provides more data linking its use to cardiovascular conditions," one researcher said. 

READ MORE >
cannabis use disorder marijuana joint weed smoking
Share on Twitter Share on Facebook Share on Linkedin

Daily marijuana use increases heart failure risk by 34%

Share on Twitter Share on Facebook Share on Linkedin
cannabis use disorder marijuana joint weed smoking
“Marijuana use isn’t without its health concerns, and our study provides more data linking its use to cardiovascular conditions," one researcher said. 
READ MORE >

ChatGPT struggles with echocardiography, but still shows potential to help cardiology trainees

ChatGPT may not be quite ready to help prepare trainees for their next echocardiography exam—but it does show promise. 

READ MORE >
artificial intelligence AI heart cardiology
Share on Twitter Share on Facebook Share on Linkedin

ChatGPT struggles with echocardiography, but still shows potential to help cardiology trainees

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI heart cardiology
ChatGPT may not be quite ready to help prepare trainees for their next echocardiography exam—but it does show promise. 
READ MORE >

In Other News

How radiology departments can decarbonize, save money

Philips and Vanderbilt University Medical Center have released findings from their efforts to reduce waste in the hospital's radiology department.

READ MORE >
Philips Vanderbilt Carbon Emissions Warning
Share on Twitter Share on Facebook Share on Linkedin

How radiology departments can decarbonize, save money

Share on Twitter Share on Facebook Share on Linkedin
Philips Vanderbilt Carbon Emissions Warning
Philips and Vanderbilt University Medical Center have released findings from their efforts to reduce waste in the hospital's radiology department.
READ MORE >

RSNA 2023: Hospital imaging systems may be gateways for ransomware, expert warns

Cybersecurity consultant Richard Staynings argued legacy medical devices are inherently insecure—and likely to remain in hospitals for decades to come.

READ MORE >
money cybersecurity ransomware health IT data breach hacker
Share on Twitter Share on Facebook Share on Linkedin

RSNA 2023: Hospital imaging systems may be gateways for ransomware, expert warns

Share on Twitter Share on Facebook Share on Linkedin
money cybersecurity ransomware health IT data breach hacker
Cybersecurity consultant Richard Staynings argued legacy medical devices are inherently insecure—and likely to remain in hospitals for decades to come.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib
News Alert: FDA shares new warning about Impella heart pumps after death
AHA takes on cardiac amyloidosis | Have clinicians been wrong about PAD? | FDA OKs new AI for heart failure
Insulin pods recalled | Cardiology groups support bill | Treating ‘broken hearts’ | AI delivers answers | Prasugrel after PCI
The high costs of robotic tech | Medtronic recalls thousands of devices | TAVR in younger patients | FDA approves next-gen valve
Heart pump controllers recalled | Concomitant EP procedures for AFib | FDA's update after deaths | Pacing techniques & TAVR

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …2
    • Page 3
    • Page 4
    • Page 5
    • Current page 6
    • Page 7
    • Page 8
    • Page 9
    • Page 10 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup